Publications by authors named "Anna M Hage"

Claim this Profile
Q
Quantitative assessment of visual designs for communicating patient-reported outcomes in breast cancer care to patients.
Lea Doppelbauer, Anna Maria Hage, Maria Margarete Karsten, Pimrapat Gebert, Anna Tatzber

J Patient Rep Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating the EORTC CAT core and the QLQ-C30 to the EQ-5D-5L in patients with metastatic breast cancer: A comparison of direct and indirect mapping algorithms.
Pimrapat Gebert, Anna Maria Hage, Felix Fischer, Christoph Paul Klapproth, Ulrike Grittner

Eur J Health Econ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.
Pimrapat Gebert, Anna Maria Hage, Jens-Uwe Blohmer, Robert Roehle, Maria Margarete Karsten

Support Care Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer.
Pimrapat Gebert, Maria Margarete Karsten, Anna Maria Hage, Adam David Dordevic, Ulrike Grittner

Trials· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype-Specific Survival of Young Women with Breast Cancer and Its Interaction with the Germline BRCA Status.
Anna Maria Hage, Pimrapat Gebert, Jens-Uwe Blohmer, Elham Hedayati, Dorothee Speiser

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients [European Journal of Cancer 163 (2022) 128-139].
Maria M Karsten, Robert Roehle, Sarah Albers, Therese Pross, Anna M Hage

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data of real-world reference scores for EORTC QLQ-C30 and QLQ-BR23 at baseline in women with early breast cancer and other breast diseases.
Pimrapat Gebert, Adam David Dordevic, Robert Roehle, Anna Maria Hage, Maria Margarete Karsten

Data Brief· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the Feasibility of an Application-Based Patient-Reported Outcome Monitoring for Breast Cancer Patients: A Pretest for the PRO B Study.
Anna Maria Hage, Pimrapat Gebert, Friedrich Kühn, Therese Pross, Ulrike Grittner

Int J Environ Res Public Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients.
Maria M Karsten, Robert Roehle, Sarah Albers, Therese Pross, Anna M Hage

Eur J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial.
Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens-Uwe Blohmer, Anna Maria Hage

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis